3,000 employees worldwide


    2,000 employees in Taiwan (2,500 worldwide)

    Signed second LOI to invest 40 Million USD in Taiwan with Ministry of Economic Affairs (MOEA)


    Established a new group company, SHL Pharma, to provide final assembly, labeling and packaging


    Established Taiwan's sixth production center – Nankan 6

    Launched Molly®, SHL's first “pre-configured” auto injector, to the pharma/biotech industry


    20th Anniversary of SHL

    Presented with Amgen Award for Operational Excellence in Quality

    Expansion of molding, tooling & automation capabilities in Taiwan

    Awarded red dot: product design 2009 for Precision Pen Injector (PPI®) device


    Signed LOI to invest 100 Million USD in Taiwan with Ministry of Economic Affairs (MOEA)

    Strengthened customer base with majority of world's leading pharmaceutical and biotech companies


    Significant investment in automation capabilities

    Improved production efficiency & enhanced quality system


    Built a modern, on-site tooling center in Taiwan with European expertise

    Continued investment in our own IP & increased number of registered patents


    SHL becomes recognized leader in the global auto injector market

    Featured in a range of media, including Financial Times, Fortune Magazine & Dagens Industri


    1000 employees worldwide

    Acquired Pertinax (now known as SHL Healthcare) and founded SHL Technologies。

    Completed 25,000m2 state-of-the-art manufacturing site in Taiwan ISO13485 certified & cGMP compliant

    Sustained annual R&D investment program established

    Established three design centers in Sweden, USA & Taiwan

    Enhanced vertical integration by through new capabilities

    Established additional manufacturing facilities in Taiwan & China


    Received ISO9001/EN46001 certification

    Designed, developed and manufactured SHL's 1st auto injector PenInject 2.25 for Pfizer

    Provide high-quality OEM/ODM manufacturing solutions

    SHL established in 1989 by Swedish entrepreneurs Roger Samuelsson and Martin Jelf as a privately held company